Recombinant UPF0098 protein Rv2140c/MT2198 is encoded by the Rv2140c/MT2198 gene in Mycobacterium tuberculosis. It belongs to the UPF0098 protein family, which is conserved across bacterial species but remains functionally uncharacterized in mycobacteria . UniProt lists it as a reviewed (Swiss-Prot) protein, confirming its existence and basic annotation in M. tuberculosis strain CDC 1551 .
The recombinant protein is expressed and purified using multiple host systems, each offering distinct advantages:
| Host System | Yield | Turnaround Time | Post-Translational Modifications |
|---|---|---|---|
| Escherichia coli | High | Shortest | Limited |
| Yeast | High | Moderate | Moderate |
| Insect cells (Baculovirus) | Moderate | Long | Extensive (e.g., glycosylation) |
| Mammalian cells | Low | Longest | Extensive (native-like folding) |
E. coli and yeast are preferred for high-throughput applications due to cost-effectiveness and scalability .
Insect and mammalian systems are used when post-translational modifications (PTMs) are critical for functional studies .
Recombinant proteins like U1 have shown 60–87% sensitivity in detecting tuberculosis antibodies, particularly in HIV-coinfected patients . While Rv2140c/MT2198 has not been tested similarly, its homology to immunogenic proteins suggests diagnostic utility.
MDP1, when combined with CpG DNA adjuvant (e.g., G9.1), enhances IFN-γ production, a key marker of vaccine efficacy . Rv2140c/MT2198 could be explored in similar adjuvant-based strategies.
Functional Characterization: The biological role of UPF0098 proteins in M. tuberculosis remains unknown, limiting targeted applications .
Optimization Needs: Balancing yield (favoring E. coli/yeast) and PTM accuracy (favoring insect/mammalian systems) requires further study .
Clinical Validation: No peer-reviewed studies directly testing Rv2140c/MT2198 in animal or human models have been published to date.
Rv2140c (also known as TB18.6) is a conserved protein in Mycobacterium tuberculosis H37Rv classified as a phosphatidylethanolamine-binding protein (PEBP), homologous to Raf kinase inhibitor protein (RKIP) in humans . It is located at coordinates 2399798-2400328 on the negative strand of the M. tuberculosis genome . The protein consists of 176 amino acids and has been identified in multiple cellular compartments including the culture supernatant, membrane fraction, and whole cell lysates of M. tuberculosis H37Rv through various proteomics studies .
Rv2140c shows significant evolutionary conservation across diverse bacterial genera. Sequence analysis reveals good similarity to hypothetical proteins from Streptomyces coelicolor (58% identity) and to the 17.1 kDa Escherichia coli protein YbhB (46.2% identity in 156 aa overlap) . This high degree of conservation suggests an evolutionarily important role despite not being essential for in vitro growth of M. tuberculosis, as demonstrated through multiple independent transposon mutagenesis studies .
Quantitative phosphoproteomic analysis comparing recombinant M. smegmatis strains expressing Rv2140c (Ms_Rv2140c) versus vector control (Ms_vec) revealed that Rv2140c differentially regulates 425 phosphorylated sites representing 282 proteins . Gene ontology (GO) and cluster of orthologous groups (COG) analyses showed that Rv2140c-regulated phosphoproteins were primarily associated with metabolism and cellular processes . Specifically, Rv2140c significantly repressed phosphoproteins involved in signaling pathways, including serine/threonine-protein kinases and two-component systems .
Experimental evidence indicates that Rv2140c significantly influences cell wall composition by upregulating phosphoproteins involved in the arabinogalactan biosynthesis pathway . Consistent with these phosphoproteomic data, heterologous expression of Rv2140c in M. smegmatis altered several phenotypic properties including:
| Phenotypic Property | Effect of Rv2140c Expression |
|---|---|
| Colony morphology | Altered appearance |
| Cell wall permeability | Modified barrier function |
| Survival in acidic conditions | Enhanced resistance |
| Lactose transport | Increased activity |
These changes suggest Rv2140c plays a crucial role in modulating cell wall integrity and composition, potentially contributing to M. tuberculosis survival under stressful host conditions .
Based on research methodologies described in the literature, a systematic approach for recombinant Rv2140c production would include:
Gene cloning into a suitable expression vector
Transformation into an appropriate expression host (E. coli or mycobacterial expression systems)
Optimization of expression conditions (temperature, inducer concentration, duration)
Cell lysis under conditions that preserve protein structure
Initial purification via affinity chromatography (if tagged constructs are used)
Secondary purification steps (ion exchange, size exclusion chromatography)
Verification of purity by SDS-PAGE and functional activity assays
When designing expression constructs, researchers should consider that Rv2140c has been identified in the membrane fraction of M. tuberculosis, suggesting potential membrane association that may affect solubility and purification strategies .
To study Rv2140c's phosphoregulatory functions, researchers have employed quantitative phosphoproteomics approaches . A recommended workflow includes:
Generation of recombinant strains expressing Rv2140c (e.g., in M. smegmatis as a surrogate host)
Growth of bacterial cultures under standardized conditions
Protein extraction and phosphopeptide enrichment
LC-MS/MS analysis for phosphopeptide identification
Quantitative comparison between Rv2140c-expressing and control strains
Bioinformatic analysis including GO and COG functional categorization
Validation of key phosphorylation changes using targeted approaches
Correlation of phosphoproteome changes with phenotypic outcomes
This approach has successfully identified hundreds of differentially regulated phosphorylation sites, providing insights into Rv2140c's regulatory network .
Based on published findings, researchers investigating Rv2140c's physiological effects should consider these assays:
| Phenotypic Assay | Purpose | Key Measurements |
|---|---|---|
| Colony morphology analysis | Evaluate impact on growth patterns | Colony size, texture, pigmentation |
| Cell wall permeability tests | Assess envelope integrity | Uptake of dyes or antibiotics |
| Acid survival assays | Measure resistance to acidic environments | Viability after acid exposure |
| Nutrient transport studies | Examine metabolite uptake capacity | Uptake rates of labeled substrates |
| Arabinogalactan composition analysis | Quantify cell wall component changes | Sugar composition by chromatography |
These assays have revealed that Rv2140c expression alters colony morphology, cell wall permeability, acid resistance, and lactose transport in M. smegmatis, suggesting similar roles in M. tuberculosis .
While focusing on distinct biological processes, both Rv2140c and Rv2145c contribute to M. tuberculosis adaptation and survival:
While Rv2140c primarily affects bacterial physiology through internal regulatory mechanisms, Rv2145c appears to function as a virulence factor by manipulating host immune responses .
Rv2140c belongs to the phosphatidylethanolamine-binding protein (PEBP) family, which includes human Raf kinase inhibitor protein (RKIP) . This evolutionary relationship suggests possible shared mechanisms despite divergent specific functions:
Both proteins likely share core structural features characteristic of the PEBP family
Both function as regulatory proteins affecting phosphorylation networks
In humans, RKIP inhibits the Raf-MEK-ERK pathway, while Rv2140c regulates bacterial phosphoproteins
Both may bind similar phospholipid ligands through conserved binding pockets
The homology between bacterial Rv2140c and human RKIP raises intriguing questions about potential molecular mimicry or convergent evolution of regulatory mechanisms across domains of life .
Researchers face several technical obstacles when investigating Rv2140c:
Complexity of phosphorylation networks - The protein affects hundreds of phosphorylation sites, making it challenging to distinguish direct from indirect effects
Redundant regulatory pathways - As a non-essential gene, functional compensation may mask phenotypes in knockout studies
Potential protein-lipid interactions - As a PEBP family member, studying its interactions with membrane components requires specialized techniques
Limited structural information - Complete three-dimensional structure determination would aid mechanistic understanding
Technical difficulties in mycobacterial genetics - Slow growth and challenging genetic manipulation of pathogenic mycobacteria
Addressing these challenges requires integrated approaches combining genetics, biochemistry, structural biology, and systems-level analyses.
Several lines of evidence suggest potential roles in pathogenesis:
Presence in culture filtrate and membrane fractions indicates potential interaction with host environment
Regulation of cell wall components (arabinogalactan) may affect bacterial resistance to host defenses
Enhanced survival in acidic conditions when expressed in M. smegmatis suggests possible contribution to phagosomal survival
Homology to human RKIP suggests potential for molecular mimicry or host-pathogen interaction
Non-essentiality in vitro does not preclude importance during infection, particularly under specific stress conditions
Further research using infection models would be necessary to definitively establish Rv2140c's role in pathogenesis.
Leading-edge approaches for deeper mechanistic insights include:
Cryo-electron microscopy for high-resolution structural determination
X-ray crystallography of Rv2140c alone and in complex with binding partners
Hydrogen-deuterium exchange mass spectrometry to map dynamic regions
Phospholipidomics to identify specific lipid binding preferences
Proximity labeling techniques to identify interaction partners in living bacteria
Time-resolved phosphoproteomics to determine the sequence of regulatory events
Single-cell approaches to examine heterogeneity in Rv2140c function within bacterial populations
Integrative multi-omics to position Rv2140c within regulatory networks
These technologies could reveal how Rv2140c selectively regulates specific phosphorylation pathways and contributes to mycobacterial adaptation.
Several research directions warrant exploration:
Determination of high-resolution three-dimensional structure to understand phospholipid and protein binding mechanisms
Identification of direct interaction partners and substrates through targeted approaches
Generation of phospho-site specific antibodies to monitor Rv2140c-dependent regulation
Investigation of Rv2140c expression and function during different stages of infection
Comparative analysis of Rv2140c homologs across pathogenic and non-pathogenic mycobacteria
Evaluation of potential cross-talk between Rv2140c and other regulatory systems in M. tuberculosis
Assessment of Rv2140c's role in antibiotic tolerance and stress response
These investigations would provide deeper insights into how this conserved regulatory protein contributes to M. tuberculosis biology.
While Rv2140c itself is non-essential for in vitro growth, its regulatory functions suggest several potential therapeutic applications:
Targeting signaling networks regulated by Rv2140c might sensitize bacteria to existing antibiotics
Understanding its role in cell wall modification could reveal new vulnerabilities in the mycobacterial envelope
Inhibitors preventing Rv2140c-mediated acid adaptation might enhance bacterial clearance in phagosomes
The protein's interaction network might reveal novel essential targets within its downstream pathways
Structural insights could enable rational design of compounds targeting specific protein-protein or protein-lipid interactions
Such approaches could potentially address challenges in tuberculosis treatment including bacterial persistence and drug resistance.
Integrated analysis of multiple M. tuberculosis proteins provides a more comprehensive understanding of pathogenesis mechanisms:
While Rv2140c modifies bacterial physiology through phosphoregulation , Rv2145c directly stimulates host IL-10 production and STAT3 activation
Both proteins contribute to a favorable environment for bacterial survival but through distinct mechanisms
Combined study of these proteins illustrates how M. tuberculosis employs both host-directed and bacterial-directed strategies
Understanding potential interactions or synergy between these pathways could reveal new intervention points
Comparative analysis helps prioritize targets for further research based on their roles in pathogenesis
This integrated perspective is essential for developing comprehensive models of M. tuberculosis virulence and adaptation.
Optimal experimental approaches would include:
Macrophage infection models comparing wild-type and Rv2140c-deficient M. tuberculosis
Animal infection studies using knockout, complemented, and overexpression strains
Dual RNA-seq to simultaneously monitor host and pathogen transcriptional responses
Time-course phosphoproteomic analysis during infection to track dynamic regulation
Co-infection experiments to assess competitive fitness in vivo
Tissue-specific analyses to examine Rv2140c's role in different microenvironments
Systems biology integration of multiple data types (transcriptomics, proteomics, metabolomics)
These approaches would provide comprehensive insights into how Rv2140c functions during the complex process of host-pathogen interaction.